关注
Sharad Darandale
Sharad Darandale
Formulation Specialist, FR&D Injectable
在 drreddys.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery
S Torne, S Darandale, P Vavia, F Trotta, R Cavalli
Pharmaceutical development and technology 18 (3), 619-625, 2013
1742013
Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization
SS Darandale, PR Vavia
Journal of inclusion phenomena and macrocyclic chemistry 75, 315-322, 2013
1682013
Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment
N Mali, S Darandale, P Vavia
Drug delivery and translational research 3, 587-592, 2013
872013
Design of a gastroretentive mucoadhesive dosage form of furosemide for controlled release
SS Darandale, PR Vavia
Acta Pharmaceutica Sinica B 2 (5), 509-517, 2012
742012
Drug delivery| bioavailability-nanosponge-aided drug delivery: a closer look
S Swaminathan, S Darandale, PR Vavia
Pharm Formul Qual 14 (5), 12-5, 2012
212012
Effect of lipid composition in propofol formulations: decisive component in reducing the free propofol content and improving pharmacodynamic profiles
SS Darandale, GB Shevalkar, PR Vavia
Aaps Pharmscitech 18, 441-450, 2017
132017
Fabrication and statistical optimization of a polysaccharide-based sublingual film of buprenorphine hydrochloride for breakthrough pain management: in vitro and in vivo performance
GS Yeola, S Darandale, A Khire, PR Vavia
Drug delivery and translational research 4, 116-125, 2014
72014
DOI: Fund: Corresponding Authors: About author
SS Darandale, PR Vavia
系统目前无法执行此操作,请稍后再试。
文章 1–8